News

Public · Published

STAAR Surgical to Participate in Upcoming Investor Conferences

STAAR Surgical said CEO Warren Foust and CFO Deborah Andrews will attend two investor conferences in New York in November 2026, with webcast fireside chats and one-on-one meetings with institutional investors.

Published:

Updated:

What happened

STAAR Surgical said CEO Warren Foust and CFO Deborah Andrews will attend two investor conferences in New York in November 2026, with webcast fireside chats and one-on-one meetings with institutional investors.

Confirmed

Global impact / market context

Investor conferences give company leaders a direct way to update portfolio managers and analysts on the business. What they say can shape how investors judge STAAR's vision-correction lens business, potentially affecting demand for the stock and how positions are sized.

Analyst inference

The meetings happen in November 2026, so management's comments will be weighed against whatever financial results and guidance are public by then. Webcasts let a wider set of investors listen, broadening who can react to the same management message.

Analyst inference

What to watch

  1. Two fireside chats are scheduled: Stifel's on November 10, 2026 at 10:00 a.m. ET, and Canaccord Genuity's on November 11, 2026 at 10:30 a.m. ET, with live and archived webcasts on STAAR's investor website. Confirmed
  2. Investors seeking a meeting should contact representatives at Stifel or Canaccord Genuity, or reach STAAR's Investor Relations team, to schedule one-on-one sessions with Mr. Foust and Ms. Andrews. Proposed
  3. Listen for management comments on sales of EVO ICL lenses and any changes to spending plans, because such remarks could shift investor expectations for revenue, costs, and the stock ahead of year-end. Analyst inference

Evidence

  • Original source link unavailable